91 related articles for article (PubMed ID: 23478248)
1. Effect of oral N-acetyl cysteine on eradication of Helicobacter pylori in patients with dyspepsia.
Karbasi A; Hossein Hosseini S; Shohrati M; Amini M; Najafian B
Minerva Gastroenterol Dietol; 2013 Mar; 59(1):107-12. PubMed ID: 23478248
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
4. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia.
Whitehead MW; Phillips RH; Sieniawska CE; Delves HT; Seed PT; Thompson RP; Powell JJ
Helicobacter; 2000 Sep; 5(3):169-75. PubMed ID: 10971683
[TBL] [Abstract][Full Text] [Related]
6. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
7. Effect of N-acetyl cysteine on Helicobacter pylori.
Gurbuz AK; Ozel AM; Ozturk R; Yildirim S; Yazgan Y; Demirturk L
South Med J; 2005 Nov; 98(11):1095-7. PubMed ID: 16351030
[TBL] [Abstract][Full Text] [Related]
8. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
[TBL] [Abstract][Full Text] [Related]
9. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
[TBL] [Abstract][Full Text] [Related]
11. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
13. Indications for treatment of Helicobacter pylori infection: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
15. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
16. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Talley NJ; Vakil N; Ballard ED; Fennerty MB
N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
[TBL] [Abstract][Full Text] [Related]
17. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
Kyzekové J; Arlt J; Arltová M
Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
[TBL] [Abstract][Full Text] [Related]
19. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
20. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
